Cases are usually diagnosed in the later stages III and IV, when the tumour has spread beyond the abdomen, the diagnosis majorly relies on imaging techniques, CA-125 blood tests, and surgical biopsies, and is associated with poor prognosis (Roett and Evans, 2009). This evidence concerns the gene MUC16 and neoplasm.